# 2026-00621: Utah Doctor's Fentanyl Lies Lead to Permanent DEA Registration Revocation

2026-00621, Mark Huff, M.D.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-01-15, effective 2026-02-17 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-00621
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-00621
- Title: Mark Huff, M.D.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 1827
- Published: 2026-01-15
- Effective: 2026-02-17
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Utah Doctor's Fentanyl Lies Lead to Permanent DEA Registration Revocation

## Summary

Dr. Mark Huff from Utah lost his DEA license because he wasn’t honest about his fentanyl abuse and treatment during a government investigation. The DEA decided his actions could harm public safety, so they ended his registration. This means Dr. Huff can no longer legally handle controlled substances, effective immediately, impacting his medical practice and patients.

## Effects PRIA read

- DEA Registration Revoked for Dr. Mark Huff: cost, high. Dr. Mark Huff’s DEA Certificate of Registration No. FH6657716 is revoked, effective February 17, 2026. This means Dr. Huff can no longer legally handle controlled substances and the revocation applies immediately on that date.
- Pending DEA Applications Denied: cost, medium. The Order also denies any pending applications of Mark Huff to renew or modify DEA registration and denies any other pending application for additional registration in Utah, effective February 17, 2026. Those pending requests will not be granted after that date.
- Patients May Lose Access To Controlled Drugs: cost, medium. Patients of Dr. Mark Huff may no longer receive prescriptions or other legally authorized access to controlled substances from him after February 17, 2026. The Order explicitly notes the revocation impacts his medical practice and patients.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-00621 on federalregister.gov](https://www.federalregister.gov/documents/2026/01/15/2026-00621/mark-huff-md-decision-and-order)
- [2026-00621 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-01-15/pdf/2026-00621.pdf)

## Related
- [Previous: 2026-00613, Notice of Request for Revision to and Extension of Approval of an Information C…](https://policyrisk.com/federal-register/2026-00613)
- [Next: 2026-00622, Proviso Railroad, Inc.-Acquisition Exemption-L. Neill Cartage Co., Inc.](https://policyrisk.com/federal-register/2026-00622)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-00621 (as of 2026-06-08).
